Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 25, 2015 1:20 PM ET

Healthcare Equipment and Supplies

Company Overview of Svelte Medical Systems, Inc.

Company Overview

Svelte Medical Systems, Inc. designs and develops balloon expandable stents for the treatment of atherosclerosis. The company offers an integrated delivery system that navigates coronary arteries like a guide wire to simplify the stenting procedure. It also develops drug-eluting stents. The company markets its products in the European Union; and selected South American countries, such as Brazil. Svelte Medical Systems, Inc. was founded in 2007 and is based in New Providence, New Jersey.

675 Central Avenue

Suite 2

New Providence, NJ 07974

United States

Founded in 2007





Key Executives for Svelte Medical Systems, Inc.

Chief Executive Officer, President and Director
Vice President of Operations
Vice President of Quality Assurance
Vice President of Sales & Marketing
Age: 79
Compensation as of Fiscal Year 2015.

Svelte Medical Systems, Inc. Key Developments

Svelte Medical Systems Reports Updates to Clinical Program

Svelte Medical Systems reported 1-year clinical results from the DIRECT II study were similar to those seen at 6-months, with non-inferiority clearly established. The company announced that target Lesion Failure (TLF), a primary clinical indicator of device efficacy, increased from 2.8% at 6-months to 3.7 % at 1-year in the Svelte arm, while TLF in the control arm reached 7.8% at the same 1-year time point. The Svelte arm also exhibited reduced procedure and device times, with trends toward reduced fluoroscopy time and contrast use compared with the control arm, confirming results observed in prior studies utilizing Svelte technologies. DIRECT II is a prospective, randomized, multi-center clinical study comparing the safety and efficacy of the Svelte drug-eluting coronary stent-on-a-wire Integrated Delivery System (IDS) and the Medtronic Resolute Integrity drug-eluting coronary stent in 159 patients undertaken in support of CE Mark certification of the Svelte IDS. Utilizing a fixed-wire design which provides the lowest crimped stent profile on the market, proprietary balloon technology for direct stenting and a new class of bioresorbable drug coating, the IDS is designed to optimize trans-radial interventions (TRI) and a 'slender' approach to PCI by downsizing catheter sizes used during intervention.

Svelte Medical Systems, Inc. Welcomes Richard Dakers to Board of Directors

Svelte Medical Systems, Inc. welcomed Richard Dakers of the Gary and Mary West Health Investment Fund to its board of directors.

Svelte Medical Systems and Asahi Intecc USA Sign Manufacturing and Co-Branding Deal

Svelte Medical Systems and Asahi Intecc reported that Svelte and Asahi Intecc USA., a subsidiary company of Asahi Intecc, executed formal agreements relating to the manufacture and co-branding of the Svelte drug-eluting coronary stent fixed wire Integrated Delivery System (IDS). The collaboration will feature ASAHI's ACTONE wire technology in the design, development and supply of core wire and coil assemblies for the Svelte IDS.

Similar Private Companies By Industry

Company Name Region
Siemens Medical Solutions Diagnostics, Inc. United States
EverHeart Systems Inc. United States
Ceretec, Inc. United States
Sekisui Diagnostics, LLC. United States
Human Care LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Svelte Medical Systems, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at